These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 26264021)

  • 1. VKORC1 and VKORC1L1: Why do Vertebrates Have Two Vitamin K 2,3-Epoxide Reductases?
    Oldenburg J; Watzka M; Bevans CG
    Nutrients; 2015 Jul; 7(8):6250-80. PubMed ID: 26264021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phylogeny of the Vitamin K 2,3-Epoxide Reductase (VKOR) Family and Evolutionary Relationship to the Disulfide Bond Formation Protein B (DsbB) Family.
    Bevans CG; Krettler C; Reinhart C; Watzka M; Oldenburg J
    Nutrients; 2015 Jul; 7(8):6224-49. PubMed ID: 26230708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two enzymes catalyze vitamin K 2,3-epoxide reductase activity in mouse: VKORC1 is highly expressed in exocrine tissues while VKORC1L1 is highly expressed in brain.
    Caspers M; Czogalla KJ; Liphardt K; Müller J; Westhofen P; Watzka M; Oldenburg J
    Thromb Res; 2015 May; 135(5):977-83. PubMed ID: 25747820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VKOR paralog VKORC1L1 supports vitamin K-dependent protein carboxylation in vivo.
    Lacombe J; Rishavy MA; Berkner KL; Ferron M
    JCI Insight; 2018 Jan; 3(1):. PubMed ID: 29321368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VKORC1L1, an enzyme rescuing the vitamin K 2,3-epoxide reductase activity in some extrahepatic tissues during anticoagulation therapy.
    Hammed A; Matagrin B; Spohn G; Prouillac C; Benoit E; Lattard V
    J Biol Chem; 2013 Oct; 288(40):28733-42. PubMed ID: 23928358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of warfarin resistance using transcription activator-like effector nucleases-mediated vitamin K epoxide reductase knockout HEK293 cells.
    Tie JK; Jin DY; Tie K; Stafford DW
    J Thromb Haemost; 2013 Aug; 11(8):1556-64. PubMed ID: 23710884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genes encoding vitamin-K epoxide reductase are present in Drosophila and trypanosomatid protists.
    Robertson HM
    Genetics; 2004 Oct; 168(2):1077-80. PubMed ID: 15514077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VKORC1L1, An Enzyme Mediating the Effect of Vitamin K in Liver and Extrahepatic Tissues.
    Lacombe J; Ferron M
    Nutrients; 2018 Jul; 10(8):. PubMed ID: 30050002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Avian interspecific differences in VKOR activity and inhibition: Insights from amino acid sequence and mRNA expression ratio of VKORC1 and VKORC1L1.
    Nakayama SMM; Morita A; Ikenaka Y; Kawai YK; Watanabe KP; Ishii C; Mizukawa H; Yohannes YB; Saito K; Watanabe Y; Ito M; Ohsawa N; Ishizuka M
    Comp Biochem Physiol C Toxicol Pharmacol; 2020 Feb; 228():108635. PubMed ID: 31639498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conserved loop cysteines of vitamin K epoxide reductase complex subunit 1-like 1 (VKORC1L1) are involved in its active site regeneration.
    Tie JK; Jin DY; Stafford DW
    J Biol Chem; 2014 Mar; 289(13):9396-407. PubMed ID: 24532791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin K epoxide reductase complex subunit 1 (VKORC1): the key protein of the vitamin K cycle.
    Oldenburg J; Bevans CG; Müller CR; Watzka M
    Antioxid Redox Signal; 2006; 8(3-4):347-53. PubMed ID: 16677080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin K epoxide reductase and its paralogous enzyme have different structures and functions.
    Sinhadri BCS; Jin DY; Stafford DW; Tie JK
    Sci Rep; 2017 Dec; 7(1):17632. PubMed ID: 29247216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of protein disulfide isomerase enhances vitamin K epoxide reductase activity.
    Chetot T; Benoit E; Lambert V; Lattard V
    Biochem Cell Biol; 2022 Apr; 100(2):152-161. PubMed ID: 35007172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural and functional insights into enzymes of the vitamin K cycle.
    Tie JK; Stafford DW
    J Thromb Haemost; 2016 Feb; 14(2):236-47. PubMed ID: 26663892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin K epoxide reductase: homology, active site and catalytic mechanism.
    Goodstadt L; Ponting CP
    Trends Biochem Sci; 2004 Jun; 29(6):289-92. PubMed ID: 15276181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New Insights on Vitamin K Metabolism in Senegalese sole (
    Beato S; Marques C; Laizé V; Gavaia PJ; Fernández I
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32429051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. VKORC1 and VKORC1L1 have distinctly different oral anticoagulant dose-response characteristics and binding sites.
    Czogalla KJ; Liphardt K; Höning K; Hornung V; Biswas A; Watzka M; Oldenburg J
    Blood Adv; 2018 Mar; 2(6):691-702. PubMed ID: 29581108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VKCFD2 - from clinical phenotype to molecular mechanism.
    Czogalla KJ; Watzka M; Oldenburg J
    Hamostaseologie; 2016 Nov; 36(Suppl. 2):S13-S20. PubMed ID: 27824210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural and functional insights into human vitamin K epoxide reductase and vitamin K epoxide reductase-like1.
    Van Horn WD
    Crit Rev Biochem Mol Biol; 2013; 48(4):357-72. PubMed ID: 23631591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VKORC1 and the vitamin K cycle.
    Garcia AA; Reitsma PH
    Vitam Horm; 2008; 78():23-33. PubMed ID: 18374188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.